Has Lawrence Karsh received payments from drug or device companies?

Yes. Drug and device makers reported $9,654,391 in general payments to Lawrence Karsh across 2,024 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lawrence Karsh did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lawrence Karsh come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lawrence Karsh

Urology · Denver, CONPI 1194766279

Payments from drug & device makers

$9,654,391in general payments, 2019–2025

Across 2,024 payments — averaging $4769.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$3.9M
Medivation LLC.$2.8M
Janssen Research & Development, LLC$1.2M
Bayer$304K
Dendreon Pharmaceuticals LLC$265K
AstraZeneca$172K
plus $1.1M from 44 others

$29,504in research payments, 2019–2025

Across 36 payments — averaging $819.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$27K
Astellas Pharma Global Development$3K
Eli Lilly$73

What the payments were for

Consulting fees$241,87634%
Speaking & faculty fees$401,11757%
Travel & lodging$48,7677%
Food & beverage$14,3152%
Education$3850%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	327	$3,922,632
Medivation LLC.	334	$2,752,194
Janssen Research & Development, LLC	325	$1,162,027
Bayer	312	$304,072
Dendreon Pharmaceuticals LLC	36	$264,827
AstraZeneca	68	$172,210
Sumitomo Pharma America, Inc.	40	$155,462
Johnson & Johnson(2 entities)	153	$134,609
Siemens Medical Solutions USA, Inc.	5	$105,835
Astellas Pharma Global Development	28	$92,913
Ferring Pharmaceuticals Inc.	80	$91,961
Astellas Pharma US Inc	106	$87,195
E.r. Squibb & Sons, L.L.C.	5	$79,195
Myovant Sciences Inc.	28	$67,010
AbbVie(2 entities)	42	$48,656
Epizyme, Inc.	15	$48,084
Ferring International Pharmascience Center US	11	$37,423
Genentech, Inc.	13	$25,104
Exelixis Inc.	2	$22,781
Merck	18	$18,513
Ferring Pharmaceuticals AS	7	$14,823
Sanofi	3	$11,651
Janssen Scientific Affairs, LLC	6	$7,468
Clovis Oncology, Inc.	6	$5,395
Janssen Global Services, LLC	2	$4,753
Foundation Medicine, Inc.	7	$3,964
Astrazeneca UK Limited	1	$2,660
Amgen	2	$2,017
Daiichi Sankyo Inc.	1	$1,845
Progenics Pharmaceuticals, Inc.	4	$1,690
Sanofi US Services Inc.	1	$1,600
Tolmar Pharmaceuticals, Inc.	1	$1,300
Eli Lilly	1	$1,050
Bioxcel Therapeutics, Inc.	1	$614
Myriad Genetic Laboratories, Inc.	3	$154
Endo Pharmaceuticals Inc.	6	$120
Novartis	2	$109
Comsort, Inc	1	$100
Telix Pharmaceuticals	4	$69
Boston Scientific	3	$62
Accord Healthcare, Inc.	2	$51
C. R. Bard, Inc. & Subsidiaries	2	$47
Tempus AI, Inc	1	$28
EMD Serono, Inc.	1	$25
Rochester Medical Corporation	1	$22
Coloplast	1	$20
Blue Earth Diagnostics	1	$20
Clarus Therapeutics Inc.	1	$19
Urogen Pharma, Inc.	1	$14
SWAN Valley Medical Incorporated	3	$0

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Erleada$132,840
XTANDI$120,315
Nubeqa$116,076
ADSTILADRIN$78,896
LYNPARZA$54,479
TALZENNA$41,217
Xofigo$34,046
ORGOVYX$21,906
JEVTANA$11,651
Rubraca$5,300
AKEEGA$5,187
RYBREVANT$4,308
CARVYKTI$4,308
Lupron Depot$3,906
FOUNDATIONACT$3,840
FOUNDATIONFOCUS$3,840
FOUNDATIONONE CDX$3,840
FOUNDATIONONE HEME$3,840
FOUNDATIONONE$3,840
PROVENGE$3,299

How this compares

$9,654,391 in reported general payments places this provider in the 95th percentile of 225 urology providers in Colorado.

See all urology providers in Colorado →

Other urology in Denver

Elizabeth SnyderDenver$53K
Juan MontoyaDenver$50K
Elias HsuDenver$23K
John TillettDenver$21K
Milford PainterDenver$13K
Nina CasanovaDenver$12K
Julien DagenaisDenver$11K
Stephen RuyleDenver$9K
Brian SmithDenver$8K
Richard HeppeDenver$8K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →